Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹106Accepted-Finance NO 32 68 KOYAMBEDU FIRST MAIN ROAD SRI AYYAPPA NAGAR CHENNAI TAMILNADU 600092 | CHENNAI | TAMIL NADU | 600092 | ₹106 | L1 | Accepted-Finance L1 Bidder |
| Sl No | Description | Qty | Unit | SIVAM REMEDIES PVT LTD L1 |
|---|---|---|---|---|
| 1.00 | Human Insulin Premixed 50 / 50 Injection – 40IU/ml
Strength : Insulin, Isophane 50%,
Insulin Biphasic as soluble Insulin 50% | 1 | 10ml Vial | 106 ₹111.3 Lowest |
| 2.00 | Tacrolimus Capsules IP 0.5mg
Strength : Each hard gelatin capsule
contains Tacrolimus IP- 0.5mg | 1 | 10 X 5 Caps | 225 ₹236.25 Lowest |
| 3.00 | Tacrolimus Capsules IP 1 mg
Strength : Each hard gelatin capsule
contains Tacrolimus IP- 1 mg | 1 | 10 X 5 Caps | 360 ₹378 Lowest |
| 4.00 | Human Insulin (Short Acting)
Injection IP
Strength : 40IU/ml | 1 | 10ml Vial | 97 ₹101.85 Lowest |
| 5.00 | Human Insulin (Intermediate Acting)
Injection IP
Strength : 40IU/ml | 1 | 10ml Vial | 97 ₹101.85 Lowest |
| 6.00 | Cyclosporine Capsules IP 50mg
Strength :
Each soft gelatin capsule contains
Cyclosporine IP- 50mg | 1 | 10 X 5 Caps | - |
| 7.00 | Cyclosporine Capsules IP 25mg
Strength : Each soft gelatin capsule
contains Cyclosporine IP- 25mg | 1 | 10 X 5 Caps | - |
| 8.00 | Mycophenolate Mofetil Tablets IP
500mg
Strength: Each film coated tablet
contains Mycophenolate Mofetil IP
500mg | 1 | 10 X 10 Tabs | 790 ₹790 Lowest |
| 9.00 | Human Insulin Premixed 30 / 70 Injection – 40IU/ml
Strength : Insulin, Isophane 70%,
Insulin Biphasic as soluble Insulin
30% | 1 | 10ml Vial | - |
Tender Value
Refer Docs
EMD Value
₹38,000
Closing Date
9 Jun 2026, 4:00 pmClosed
General Manager (Drugs)
TNMSC Limited, No. 417, Panthon Road, Egmore, Chennai - 600008
Online Tender for the supply of Drugs to Sales Counter of TNMSC Limited under rate contract system for two years from the date of acceptance
2026_TNMSC_677415_1
e-010/M(P)/SALE /TNMSC/2026
Open Tender
Medicines
Supply
30 days
TamilNadu
Please refer Tender documents.
25 documents required · 25 mandatory
₹0
₹38,000
Yes
22 Jul 2026
19 May 2026
9 Jun 2026
19 May 2026
9 Jun 2026
1 Jun 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | Human Insulin Premixed 50 / 50 Injection – 40IU/ml
Strength : Insulin, Isophane 50%,
Insulin Biphasic as soluble Insulin 50% | 1 | 10ml Vial | - | - |
| 2 | Tacrolimus Capsules IP 0.5mg
Strength : Each hard gelatin capsule
contains Tacrolimus IP- 0.5mg | 1 | 10 X 5 Caps | - | - |
| 3 | Tacrolimus Capsules IP 1 mg
Strength : Each hard gelatin capsule
contains Tacrolimus IP- 1 mg | 1 | 10 X 5 Caps | - | - |
| 4 | Human Insulin (Short Acting)
Injection IP
Strength : 40IU/ml | 1 | 10ml Vial | - | - |
| 5 | Human Insulin (Intermediate Acting)
Injection IP
Strength : 40IU/ml | 1 | 10ml Vial | - | - |
| 6 | Cyclosporine Capsules IP 50mg
Strength :
Each soft gelatin capsule contains
Cyclosporine IP- 50mg | 1 | 10 X 5 Caps | - | - |
| 7 | Cyclosporine Capsules IP 25mg
Strength : Each soft gelatin capsule
contains Cyclosporine IP- 25mg | 1 | 10 X 5 Caps | - | - |
| 8 | Mycophenolate Mofetil Tablets IP
500mg
Strength: Each film coated tablet
contains Mycophenolate Mofetil IP
500mg | 1 | 10 X 10 Tabs | - | - |
| 9 | Human Insulin Premixed 30 / 70 Injection – 40IU/ml
Strength : Insulin, Isophane 70%,
Insulin Biphasic as soluble Insulin
30% | 1 | 10ml Vial | - | - |
stage.html
html • 0.03 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.04 MB
Tendernotice_1.pdf
PDF • 0.09 MB
SaleCounterTenderDocumentFinal010.pdf
Tender Documents • 1.82 MB
BOQ_813949.xls
BOQ • 0.35 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].